Saturday, August 29, 2015 7:49:47 AM
were losing possible contracts. I'm sure any company submitting an RFQ would also look up the
background on those they are dealing with..especially with a penny stock company with little
infrastructure for support of any contract. Also LQMTs financial position. Perhaps thats' why they are
continuing to pay him. Because the cause was his background that was affecting getting contracts.
Perhaps even ENGEL was behind his release, maybe hearing from possible clients that they weren't
going to sign up to anything unless those with tainted backgrounds at LQMT were removed.
Hate to say it, but the 2006 investigation, the enormous stock dilution and also, if I may, Steipps
request for a million dollar pay raise, may be a big negative for possible clients. That's why its good
to have ENGEL with their world renowned reputation. As I said before, I hope ENGEL becomes
more in the forefront of activities and LQMT takes more of a back seat. ENGEL has use of the patents,
they have their own sales team, they have manufacturing entities, and have the funds to expand.
What does LQMT have?? Very little. Steipp may say he has his eye on larger facilities for more machines if needed, but he's looking for "low hanging fruit". ENGEL is looking for Whales. I hope they have one on the line. ENGEL has infrastructure. Design/engineers and scientists. I have a feeling
the momentum is going to start going to ENGEL as I surmised that it was ENGEL that got the EUROPEAN contract NOT LQMT.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM